Shanghai Pharmaceuticals Controlling Shareholder to Increase H-Share Stake by 11 Million to 22 Million Shares

Stock News11-04

Shanghai Pharmaceuticals Holding Co.,Ltd. (601607.SH) has announced that its controlling shareholder, Shanghai Industrial (Group) Co., Ltd., plans to increase its holdings of the company's H shares through centralized bidding via the Hong Kong Stock Exchange system over the next 12 months, through its wholly-owned subsidiary Shanghai Industrial International Investment Limited ("SIIC International"), with the total increased shares ranging from 11 million to 22 million shares, not exceeding 1% of the company's voting shares.

SIIC International increased its holdings by 800,000 H shares of the company on November 2, 2026. Following the increase, SIIC International holds 375 million H shares of the company, accounting for 10.119% of the company's total share capital.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment